AQN vs CWEN

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

CWEN exhibits a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect. The current price of $39.58 trades at a massive premium to both the Graham Number ($22.76) and the growth-based Intrinsic Value ($10.01). Most critically, the dividend payout ratio of 123.64% indicates an unsustainable distribution policy, while negative ROE and high debt obligations create significant long-term risk despite strong top-line revenue growth.